No Data
Do Options Traders Know Something About DMC Global (BOOM) Stock We Don't?
De Motu Cordis (DMC) Applauds ARS Pharma's FDA Approval of Neffy, Expanding Patient Options to Needle-Free Epinephrine Delivery and Inspiring Confidence in Our Own Development Efforts
DMC Global (BOOM) Receives a Buy From Roth MKM
DMC Global Is Maintained at Buy by Stifel
Stifel Maintains DMC Global(BOOM.US) With Buy Rating, Cuts Target Price to $19
Stifel analyst Stephen Gengaro maintains $DMC Global(BOOM.US)$ with a buy rating, and adjusts the target price from $24 to $19.According to TipRanks data, the analyst has a success rate of 40.3% and
Express News | DMC Global Inc : Stifel Cuts Target Price to $19 From $24